BioStem acquires BioTissue’s surgical and wound care assets in $40m deal
BioStem said the acquisition will support its advancement into ‘high value’ adjacent market segments.
23 January 2026
23 January 2026
BioStem said the acquisition will support its advancement into ‘high value’ adjacent market segments.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.